Microbot Medical Inc
MBOT
Get informed when a big investor buys or sells
+ FollowMarket Cap$52.86M
Close$
$0.07
94.3% downside
Current Fair Value
94.3% downsideOvervalued by 94.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $52.86 Million |
|---|---|
| Enterprise Value | $50.59 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.29 |
| Beta | 1.03 |
| Outstanding Shares | 67,163,613 |
Return
| Return on Equity | -11.84% |
|---|---|
| Return on Assets | -11.12% |
| Return on Invested Capital | -19.88% |
Valuation & Multiples
| P/E Ratio | -4.45 |
|---|---|
| PEG | -7.32 |
| Price to Sales | - |
| Price to Book Ratio | 1.16 |
| Enterprise Value to Revenue | 146.2 |
| Enterprise Value to EBIT | -3.66 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$133,333
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$916,667
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8870▼ 70.32% |
|---|---|
| Total Calls | 177,800▲ 9.33% |
| Total Puts | 157,700▼ 39.02% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 16.96%▼ 4.24% |
|---|---|
| Total Invested | $22.20M▼ 35.29% |
| Investors Holding | 76▼ 10.00% |
ESG Score
No data
About Microbot Medical Inc
15 employees
CEO: Harel Gadot Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary...